PROCEPT BioRobotics Corporation logo PRCT - PROCEPT BioRobotics Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 11
HOLD 3
SELL 1
STRONG
SELL
0
| PRICE TARGET: $42.40 DETAILS
HIGH: $62.00
LOW: $30.00
MEDIAN: $35.00
CONSENSUS: $42.40
UPSIDE: 46.21%

About PROCEPT BioRobotics Corporation (https://www.procept-biorobotics.com)

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

Key Executives

NAME TITLE DOB SALARY
Larry L. Wood President, Chief Executive Officer & Director 1966 $2,340,003 USD
Kevin Waters Executive Vice President & Chief Financial Officer 1977 $765,898 USD
Alaleh Nouri EVice President, Chief Legal Officer & Corporate Secretary 1979 $699,426 USD
Barry Templin Executive Vice President & Chief Technology Officer
Bijesh Chandran Executive Vice President of Regulatory Affairs & Quality Assurance
Christofer Christoforou Executive Vice President of Operations 1970
Matthew James Bacso Vice President of Investor Relations
Pooja Sharma Rao Executive VP and Chief Strategy & Marketing Officer
Stacey L. Porter Executive VP & Chief People Officer 1975
Stephen J. McGill Senior VP & GM of International 1962

Company Peers

Peer analysis pending, check back in 1-2 minutes.